You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Leukaemia
Cancer
Blood Cancer
Cancer Treatment
Breast Cancer
HPV
Topics

Advertisement

Leukaemia

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

Local crew completes Top Gear-style charity drive for Blood Cancer UK The Ross Gazette 1d

The Ross Gazette 1d

Herefordshire Scotland

EHA 2026: Fixed-duration triplet therapy demonstrates efficacy for patients with relapsed/refractory CLL ecancer 6d

ecancer 6d

Blood Cancer Cancer Treatment

Richard Herring reveals he has 'incurable blood cancer' The Times of India 7d

The Times of India 7d

Richard Herring Taskmaster

Advertisement

Advertisement

EHA26: AvenCell’s Avc-201-01 switchable allogeneic CAR T offers early validation in AML Pharmaceutical Technology 12:05 Tue, 16 Jun

Pharmaceutical Technology 12:05 Tue, 16 Jun

International panel releases consensus recommendations for pediatric AML Hematology Advisor 2d

Hematology Advisor 2d

Twin dies just weeks after identical sister's desperate attempt to fund potentially life-saving treatment The Mirror 7d

The Mirror 7d

Advertisement

Advertisement

Latest

In the last 2 hours

ASSURE Confirms Long-Term Efficacy of Acalabrutinib in CLL Hematology Advisor 14:56

In the last 6 hours

Give blood — help a critical shortage | Other views Chico Enterprise-Record, California 11:33

Earlier Today

Mabwell Receives Ind Clearance from NMPA for LILRB4/CD3-targeting Tce Bispecific Antibody 6MW5311 PR Newswire (Press Release) 01:06

Yesterday

Pirtobrutinib Combination “Potential New Standard-of-Care Option” in R/R CLL Hematology Advisor 16:58 Tue, 23 Jun

Olverembatinib With Low-Intensity Chemotherapy Shows Promise in Newly Diagnosed Ph+ ALL Hematology Advisor 15:26 Tue, 23 Jun

From "two weeks to live" to the starting line - Adam Claxton to take on Worcester City Run Worcester Observer 06:42 Tue, 23 Jun

Local crew completes Top Gear-style charity drive for Blood Cancer UK The Ross Gazette 06:11 Tue, 23 Jun

Hollyoaks' Mercedes to uncover Jenson's secret ahead of tragic hospital news Digital Spy 00:05 Tue, 23 Jun

Monday

International Panel Releases Consensus Recommendations for Pediatric AML Hematology Advisor 14:56 Mon, 22 Jun

CPX-351 Outperforms Standard Care as Transplant Bridge in MDS and AML Hematology Advisor 14:56 Mon, 22 Jun

Advertisement

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
- Cancer Cancer
  Back to Health Cancer
  - Blood Cancer
  - Breast Cancer
  - Cancer Research
  - Cancer Treatment
  - CAR-T CAR-T
  - Cervical Cancer
  - Cervical Screening
  - Colorectal Cancer
  - HPV HPV
  - Leukaemia Leukaemia
  - Lung Cancer
  - Ovarian Cancer
  - Prostate Cancer